期刊文献+

阿尔采末病胆碱能学说研究进展 被引量:20

Advance in research on cholinergic theory of Alzheimers disease
下载PDF
导出
摘要 中枢胆碱能系统参与调节哺乳动物的神经元兴奋性、皮质可塑性以及学习记忆过程 ,与脑认知功能密切相关。阿尔采末病 (Alzheimersdisease ,AD)是老年性痴呆的最常见原因 ,主要表现为进行性的认知功能下降。基底前脑胆碱能损伤导致的中枢胆碱能系统功能低下是AD患者认知功能障碍的基础。在AD病程中存在一个恶性循环 ,即脑内的胆碱能神经传递早期受损 ,导致神经退行性病变的易损区内Aβ的大量产生以及tau蛋白过度磷酸化 ,而Aβ又进一步削弱胆碱能神经传递的效应 。 It is generally agreed that the central cholinergic system plays an important role in learning and memory processes. Alzheimers disease (AD), the most common cause of dementia, is a devastating illness characterized by progressive cognitive deterioration. The learning and cognitive deficits observed in AD patients are hypothesized to be partly caused by central cholinergic system dysfunction. There exists a malicious cycle in the pathologic course of AD, that is, the impairment of central cholinergic transmission could increase the amount of Aβ in the brain, and the increase of Aβ could also impair the efficacy of the cholinergic transmission.
出处 《中国药理学通报》 CAS CSCD 北大核心 2003年第7期727-731,共5页 Chinese Pharmacological Bulletin
基金 国家重点基础研究"973"子课题 NoG19980 5110 6
关键词 阿尔采末病 乙酰胆碱 中枢胆碱能系统 痴呆 Alzheimers disease acetylcholine central cholinergic system dementia
  • 相关文献

参考文献25

  • 1[1]Felician O, Sandson TA. The neurobiology and pharmacotherapy of Alzheimers disease. J Neuropsychiatry Clin Neurosci, 1999;11:19~31
  • 2[2]Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science, 1982;217:408~16
  • 3[3]Robbins TW, McAlonan G, Muir JL, Everitt BJ. Cognitive enhancers in theory and practice: Studies of the cholinergic hypothesis of cognitive deficits in Alzheimers disease. Behav Brain Res, 1997;83:15~23
  • 4[4]Beatty WW, Butters N, Janowsky DS. Patterns of memory failure after scopolamine treatment: Implications for the cholinergic hypothesis of dementia. Behav Neural Biol, 1986;45:196~211
  • 5[5]Park GA, Pappas BA, Murtha SM, Ally A. Enriched environment primes forebrain choline acetyltransferase activity to respond to learning experience. Neurosci Lett, 1992;143:259~62
  • 6[6]Fadda F, Melis F, Stancampiano R. Increased hippocampal acetylcholine release during a working memory task. Eur J Pharmacol, 1996;307:R1~2
  • 7[7]Solomon PR, Groccia-Ellison ME, Flynn D et al. Disruption of human eyeblink conditioning after central cholinergic blockade with scopolamine. Behav Neurosci, 1993;107:271~9
  • 8[8]Kronforst-Collins MA, Moriearty PL, Schmidt B, Disterhoft JF. Metrifonate improves associative learning and retention in aging rabbits. Behav Neurosci, 1997;111:1031~40
  • 9[9]Francis PT, Sims NR, Procter AW, Bowen DM. Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimers disease: Investigative and therapeutic perspectives. J Neurochem, 1993;60:1589~604
  • 10[10]Tuszynski MH, U HS, Amaral DG, Gage FH. Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci, 1990;10:3604~14

共引文献20

同被引文献151

引证文献20

二级引证文献193

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部